J. Andrew Orr-Skirvin

Chair and Associate Clinical Professor, Department of Pharmacy and Health Systems Sciences, Director of Pharmaceutical Industry Fellowship Program

Department of Pharmacy and Health Systems Sciences, School Leadership Team, School of Pharmacy

Office: 140 The Fenway, X205

Email: j.skirvin@northeastern.edu

Phone: 617-373-4166

View Résumé/CV

Education:
Oregon State University, Bachelor of Science in Pharmacy, 1992
University of Texas at Austin, Doctor of Pharmacy, 1995
Southwest Veterans Hospital, Audie Murphy Division, Oncology Speciaility Pharmacy Residency 1995-1996.

Certification: Board Certified Oncology Pharmacist 2000

Specializations: Hematology/Oncology Pharmacy Practice

Research:
Supportive care for the cancer patient including: pain management, nausea & vomiting, neutropenic fever, long term complications, growth factor support, etc.

Public Service: Service to cancer patients through my clinical practice site.

Publications:
Skirvin JA, Patel P. Update on FDA approvals and selected investigational agents. Newsletter, Hematology/Oncology Pharmacy Association, HOPA News, Winter 2006;5-7.
Skirvin JA. Chapter 44, Thrombocytopenia. In Tisdale JE, Miller, DA, editors. Drug-Induced Diseases, prevention, detection, and management. American Society of Health-System Pharmacists. Bethesda, MD; 2005:649-60.
Skirvin JA, Lichtman SM: Pharmacokinetic considerations of oral chemotherapy in elderly cancer patients. Drugs Aging 2002;19:25-42.
Skirvin JA. Melanoma: current detection and management strategies. US Pharmacist Health-System edition 2001;Supplement September:17-28.
Skirvin JA, Vemulapalli S, Lichtman SM: Pharmacology of antineoplastic agents in older cancer patients. Oncology Spectrum 2001;2:404-13.
Skirvin JA, Gorowski E, D’Olimpio JT. Promoting in-patient pain management at a university hospital with comprehensive needs assessment. Proceedings of ASCO 2001;20:304b.
Lichtman S, Skirvin JA. Pharmacology of antineoplastic agents in older cancer patients. Oncology 2000;14:1743-55
Skirvin JA, D’Olimpio JT, Gorowski E. Pain assessment survey of adult oncology admissions: a performance improvement project (Abstract). Proceedings of ASCO 2000,19:640a.
Skirvin JA. Topotecan. CancerRX in Cancer Therapeutics 1999;2:121-5.
Stirling A, Kao E, Skirvin J, Hirsch B. Impact of pharmacist-run aminoglycoside once daily program in a tertiary teaching institution (Abstract). Pharmacotherapy 1999;19:517.
Skirvin JA, Lichtman SM, Negri A, et al. Pharmacist intervention program monitoring filgrastim use in hospitalized patients (Abstract 2252). Proceedings of ASCO 1999;18:583a.
Taibbi R, Kao E, Skirvin JA, et al. Development of an performance improvement program to increase the safety of chemotherapy administration (Abstract 2343). Proceedings of ASCO 1999;18:607a.
Stirling A, Kao E, Skirvin J, Hirsch B. Impact of pharmacist-run aminoglycoside once daily program in a tertiary teaching institution (Abstract). Pharmacotherapy 1999;19:517.
Castanheira D, Marzella M, Skirvin JA. Administration of filgrastim in two patients with drug-induced agranulocytosis. Pharmacotherapy 1998;18:1347-51.
Skirvin JA, Relias V. Topoisomerase Inhibitors: 2. Irinotecan. J Oncol Pharm Practice 1998;4:103-16.
Skirvin JA, Valley AW, Relias V, Morris AK. 6-Mercaptopurine hepatoxicity during acute lymphocytic leukemia maintenance therapy. J Oncol Pharm Practice 1998;4:117-20.
Skirvin JA, Brocavich JM. IV Immunoglobulin Therapy in Immunosuppressed Patients. US Pharmacist health-system edition 1998;23:HS-37-48.
Relias V, Skirvin JA. Topoisomerase I inhibitors: 1. Topotecan. J Oncol Pharm Practice 1997;3:173-85.
Skirvin JA, consultant. Nurse ProCalc: make-a-test, version 2.0. Microsoft Windows 3.1, Windows 95 compatible. In: Brown P, Brown ED. Nurse ProCalc: make-a-test, version 2.0. Chapel Hill: Professional Development Software, 1997, Updated in 2005.
Skirvin JA. Kaposi’s sarcoma: new treatment options. Newsletter, Long Island Society of Hospital Pharmacists 1997 April;27(8):1-2.
Skirvin JA, Relias V, Koeller J. Long-term sequelae of chemotherapy. Highlights in Oncology Practice 1996;14:26-34.
Skirvin JA. Morphine use in renal failure. Newsletter, Long Island Society of Hospital Pharmacists 1996 September;27(1):1.
Skirvin A. New Drug: Gabapentin (newsletter). Current Therapeutic Issues 1994 November; 9(1):1.
Skirvin A, Knodel LC. Efficacy of desipramine in attention deficit hyperactivity disorder (Drug Consult). In: Gelman CR, Rumack BH, editors. Drugdex® Information System. Denver: Micromedex, Inc., 1994.
Skirvin A, Kraynak MA. Role of cisapride in the therapy of chronic intestinal pseudo-obstruction in pediatrics (Drug Consult). In: Gelman CR, Rumack BH, editors. Drugdex® Information System. Denver: Micromedex, Inc., 1994.
Wanke LA, Skirvin JA. Physostigmine Therapy of Intrathecal Baclofen Overdose (Drug Consult). In: Gelman CR, Rumack BH, editors. Drugdex® Information System. Denver: Micromedex, Inc., 1992.